Sardona Therapeutics built a leading drug discovery platform to identify new small molecules to target RNA-binding proteins (RBP) and modulate RBP-driven biology for the treatment of cancer and other diseases. The platform’s foundation is our proprietary RBP Topography Map that links different RBPs to specific therapy-resistant cancers. We leverage internally developed screening assays, bioinformatics capabilities and focused small molecule compound libraries to generate best-in-class drug candidates that target individual RBPs. We also believe there are important targets and applications beyond oncology, where Sardona’s platform can identify novel drug leads.
Company Details
- Employees
- 3
- Founded
- 2020
- Address
- 953 Indiana Street, San Francisco,california 94107,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.sardonatx.com
- HQ
- San Francisco, California
Sardona Therapeutics Questions
Sardona Therapeutics's website is http://www.sardonatx.com
Sardona Therapeutics's LinkedIn profile is https://www.linkedin.com/company/sardonatx
Sardona Therapeutics has
3 employees.
View email and phone details for 3
employees at Sardona Therapeutics.
Sardona Therapeutics's industry is
Biotechnology Research
Sardona Therapeutics's top competitors are
Tahoe Therapeutics,
Pliant Therapeutics,
Navega Therapeutics,
Exai Bio,
Auron Therapeutics, Inc.,
Estuary Biotherapeutics, Inc.,
Recludix Pharma,
Verge Genomics,
Rondo Therapeutics,
Actym Therapeutics, Inc..
Sardona Therapeutics's categories are Biotechnology Research
Sardona Therapeutics's founding year is 2020
